Clinical trial
the Impact of Allopurinol of HRQOL in Cirrhotic Patients
NCT05828836 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- the Impact of Allopurinol of HRQOL in Cirrhotic Patients
- Lead sponsor
- Tanta University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 15, 2022
- Completion date
- March 1, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis, liver